1. Home
  2. ACIU vs VELO Comparison

ACIU vs VELO Comparison

Compare ACIU & VELO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AC Immune SA

ACIU

AC Immune SA

HOLD

Current Price

$2.81

Market Cap

288.0M

Sector

Health Care

ML Signal

HOLD

Logo Velo3D Inc.

VELO

Velo3D Inc.

HOLD

Current Price

$19.12

Market Cap

306.0M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACIU
VELO
Founded
2003
2014
Country
Switzerland
United States
Employees
N/A
134
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
288.0M
306.0M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
ACIU
VELO
Price
$2.81
$19.12
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
1
Target Price
$10.00
$18.00
AVG Volume (30 Days)
262.2K
3.2M
Earning Date
05-12-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$706.75
$42.22
Revenue Next Year
$321.13
$50.08
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.60
$2.87
52 Week High
$4.00
$23.84

Technical Indicators

Market Signals
Indicator
ACIU
VELO
Relative Strength Index (RSI) 43.93 62.90
Support Level $2.80 $12.06
Resistance Level $3.13 $23.84
Average True Range (ATR) 0.17 1.82
MACD -0.02 0.60
Stochastic Oscillator 31.00 71.26

Price Performance

Historical Comparison
ACIU
VELO

About ACIU AC Immune SA

AC Immune SA is a clinical stage biopharmaceutical company advancing a portfolio of programs strategically focused on pioneering Precision Medicine for neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company has one segment. The company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.

About VELO Velo3D Inc.

Velo3D Inc provides additive manufacturing (AM), also referred to as three-dimensional printing (3D printing), to deliver breakthroughs in performance, cost, and time in the production of high-value metal parts. The Velo3D intelligent metal additive manufacturing solution is comprised of the Velo3D Flow intelligent print preparation software, the Sapphire production system, and Velo3D Assure, real-time quality assurance software. Its complete manufacturing solution enables clients to build the parts needed, speed their development, and reduce their product costs.

Share on Social Networks: